SCHEMBL742153

SCHEMBL742153

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccc(CN4CCCC4)cc3)n[nH]c2s1)c1ccccc1F

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.60
BCR P11274 2/20 0.60
CYP2C9 P11712 1/20 0.44
AURKA O14965 4/20 0.42
HRH3 Q9Y5N1 2/20 0.42
DYRK1A Q13627 2/20 0.41
WNT1 P04628 1/20 0.41
KDR P35968 2/20 0.39
KIT P10721 2/20 0.39
FLT3 P36888 1/20 0.39
HIF1A Q16665 1/20 0.39
EPAS1 Q99814 1/20 0.39
TNF P01375 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
NTRK1 P04629 3/20 0.37
GSK3B P49841 1/20 0.37
ALK Q9UM73 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL741946 0.99 ABL1 (0.61) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL739473 0.99 ABL1 (0.61) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL742867 0.98 ABL1 (0.58) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL740144 0.93 ABL1 (0.52) ABL1BCRAURKAKDRFLT3
SCHEMBL2431018 0.91 ABL1 (0.62) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL742638 0.90 ABL1 (0.74) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL740797 0.89 ABL1 (0.59) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL740752 0.89 ABL1 (0.76) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL741183 0.89 ABL1 (0.76) ABL1BCRCYP2C9AURKAHRH3
SCHEMBL742130 0.89 ABL1 (0.64) ABL1BCRCYP2C9AURKAKDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
EP-2007380-B1 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF PARTICULAR RESISTANT TUMORS NERVIANO MEDICAL SCIENCES SRL (IT) 2011-09-14 EP claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed
EP-2007380-B1 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF PARTICULAR RESISTANT TUMORS NERVIANO MEDICAL SCIENCES SRL (IT) 2011-09-14 EP disclosed